About Cipesta 250mg
Cipesta 250mg Tablet helps treat severe bacterial infections. It is an antibiotic and works with the specific strains of bacteria. It contains ciprofloxacin, which belongs to the fluoroquinolone family of drugs. Cipesta 250mg Tablets are helpful for both children and adults.
How effective is Cipesta 250mg?
Cipesta 250mg Tablets are among the most effective treatments available for the bacterial infections of the respiratory tract, urinary tract, genital tract infections in men and women, stomach and intra-abdominal infections, skin and soft tissue, bone and joint disorders. It also treats long-lasting and recurring ear or sinus infections. It works by managing patients with low white blood cell counts (neutropenia) who have a fever that is suspected to be caused by a bacterial infection.
What dose should I choose?
For adults (ages 18 years and older), take an oral dosage of 1-2 Cipesta 250mg Tablets a day.
For children (ages 0 to 17 years), take an oral dosage of 20mg/kg of body weight per day.
Duration for both adults and children ranges for 7-14 days.
Try not to exceed the given dosage. If you have any medication queries, consult with your doctor.
What are the side effects and other warnings when taking Cipesta 250mg?
All products with an active ingredient can cause side effects, although they are rare.
Side effects can include:
- Muscle pain.
- Weakness.
- Inflammation and pain in the joint.
- Tendon rupture.
- Unusual feelings of pain, burning, tingling, numbness, or muscle weakness in the extremities.
- Severe allergic reactions.
These effects tend to be temporary and may disappear when your body adjusts to this medication. You should stop the use immediately and consult your doctor or a pharmacist if an allergic reaction occurs.
If you are pregnant, might become pregnant, or think you may be pregnant or breast-feeding or planning to breast-feed, notify your doctor or a pharmacist.
If you have any concerns about any potential side effects, please speak to the experts.
Reviews
There are no reviews yet.